Eversept Partners, LP Celldex Therapeutics, Inc. Transaction History

Eversept Partners, LP

$1.33 Billion
Q1 2024

A detailed history of Eversept Partners, LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 711,115 shares of CLDX stock, worth $23.7 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares

711,115

Previous 754,107 5.7%

Holding current value

$23.7 Million

Previous $29.9 Million 0.21%

% of portfolio

2.24%

Previous 2.92%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $1.51 Million - $2.23 Million	-42,992 Reduced 5.7%	711,115 $29.8 Million
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $3.75 Million - $6.75 Million	165,964 Added 28.22%	754,107 $29.9 Million
Q3 2023 Nov 14, 2023	SELL	$25.45 - $37.46 $5.03 Million - $7.4 Million	-197,597 Reduced 25.15%	588,143 $16.2 Million
Q2 2023 Nov 08, 2023	BUY	$30.29 - $38.28 $2.91 Million - $3.68 Million	96,064 Added 13.93%	785,740 $26.7 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $2.91 Million - $3.68 Million	96,064 Added 13.93%	785,740 $26.7 Million

Q1 2023 Nov 08, 2023	BUY	$34.78 - $47.43 $4.55 Million - $6.21 Million	130,902 Added 23.43%	689,676 $24.8 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $4.55 Million - $6.21 Million	130,902 Added 23.43%	689,676 $24.8 Million
Q4 2022 Nov 08, 2023	SELL	$27.78 - $45.38 $1.88 Million - $3.07 Million	-67,598 Reduced 10.79%	558,774 $24.9 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $1.88 Million - $3.07 Million	-67,598 Reduced 10.79%	558,774 $24.9 Million
Q3 2022 Nov 08, 2023	BUY	$22.7 - $37.57 $1.68 Million - $2.78 Million	73,984 Added 13.39%	626,372 $17.6 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $1.68 Million - $2.78 Million	73,984 Added 13.39%	626,372 $17.6 Million
Q2 2022 Nov 08, 2023	SELL	$20.5 - $37.33 $1.72 Million - $3.14 Million	-84,065 Reduced 13.21%	552,388 $14.9 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $1.72 Million - $3.14 Million	-84,065 Reduced 13.21%	552,388 $14.9 Million
Q1 2022 Nov 08, 2023	SELL	$27.64 - $39.32 $4.13 Million - $5.87 Million	-149,287 Reduced 19.0%	636,453 $21.7 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $1.22 Million - $1.73 Million	43,975 Added 7.42%	636,453 $21.7 Million
Q4 2021 Nov 08, 2023	SELL	$35.68 - $56.27 $6.9 Million - $10.9 Million	-193,262 Reduced 24.6%	592,478 $22.9 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $21.1 Million - $33.3 Million	592,478 New	592,478 $22.9 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $2.26 Million - $3.42 Million	-150,494 Closed	0 $0
Q3 2020 Nov 08, 2023	SELL	$9.65 - $15.19 $5.43 Million - $8.54 Million	-562,204 Reduced 78.88%	150,494 $2.23 Million
Q3 2020 Nov 13, 2020	SELL	$9.65 - $15.19 $5.43 Million - $8.54 Million	-562,204 Reduced 78.88%	150,494 $2.23 Million
Q2 2020 Nov 08, 2023	SELL	$1.61 - $13.41 $117,597 - $979,493	-73,042 Reduced 9.3%	712,698 $9.27 Million
Q2 2020 Aug 13, 2020	BUY	$1.61 - $13.41 $1.15 Million - $9.56 Million	712,698 New	712,698 $9.27 Million

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

61.2M

Call Options Held

291K

Put Options Held

246K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.56B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account

Eversept Partners, LP Celldex Therapeutics, Inc. Transaction History